Key result
Pyridostigmine-induced Mobitz Type II block and alternating bundle branch block in a patient with myasthenia gravis can masquerade as acute coronary syndrome.
Why the study?
To present the significance of alternating bundle branch block and highlight how conditions like myasthenia gravis can lead to misdiagnosing ACS in patients with dynamic ECG changes.
Case Report (n=1)
Alternating bundle branch block or pyridostigmine-induced Mobitz Type II block in patients with myasthenia gravis can masquerade as acute coronary syndrome.
Background “ST-T changes in the ECG!!” These words are enough to get the emergency doctor to spring into action. These changes can be diffuse and/or non-specific but we should rule out all emergent and urgent causes before shifting the patient to the specialist. To err on the side of dangerous etiology is the dictum. Introduction Out of all emergency department (ED) patients with undifferentiated chest pain, 7% will have ECG findings consistent with acute ischemia or infarction, and 6–10% of those in whom cardiac markers are ordered will have initially positive results. Of all patients with the possible acute coronary syndrome (ACS), 5–15% ultimately prove to have ACS.1 Shortness of breath with chest pain mostly has a cardiac origin in the presence of dynamic ECG changes. We had managed a patient with rapidly evolving ECG changes, chest pain, palpitations, and grade III–IV dyspnea. In the chaotic environment of a busy ED, the most probable diagnosis here will be ACS. Comorbid conditions like diabetes mellitus, hypertension, and prior coronary artery disease (CAD) are commonly enquired. However, other long-standing illnesses like myasthenia gravis (MG), as in our patient can be easily missed if a patient is not forthcoming with history. We experienced a similar confusion when in the cacophony of chest pain, dyspnea, and T wave inversions with bundle branch blocks, ACS protocol was initiated and a simple diagnosis was missed. The significance of the alternating bundle branch block (ABBB) will be presented to the readers. How to cite this article Hymavathi A, Uppaluri SC, Sharma A. Alternating Bundle Branch Block or Pyridostigmine-induced Mobitz Type II Block Masquerading as Acute Coronary Syndrome. J Med Acad 2020;3(2):63–66.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2020) conducted a case report in Alternating bundle branch block or pyridostigmine-induced Mobitz Type II block (n=1). Pyridostigmine was evaluated. Pyridostigmine-induced Mobitz Type II block and alternating bundle branch block in a patient with myasthenia gravis can masquerade as acute coronary syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: